메뉴 건너뛰기




Volumn 42, Issue 5, 2005, Pages 316-318

Formulation and release characteristics of sustained release ofloxacin tablet

Author keywords

Hydroxypropylmethylcellulose; Ofloxacin; Sustained release

Indexed keywords


EID: 58149088126     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (8)
  • 2
    • 0001439530 scopus 로고
    • Biopharmaceutic and pharmacokinetic aspects in the design of controlled release peroral drug delivery systems
    • Ritschel WA: Biopharmaceutic and pharmacokinetic aspects in the design of controlled release peroral drug delivery systems, Drug Dev. Ind. Pharm. 1989, 15(6 and 7), 1073-1103.
    • (1989) Drug Dev. Ind. Pharm. , vol.15 , Issue.6-7 , pp. 1073-1103
    • Ritschel, W.A.1
  • 3
    • 0030657939 scopus 로고    scopus 로고
    • Diffusion coefficients of polymer chains in the diffusion layer adjacent to a swollen hydrophilic matrix
    • Ju R.T.C., Nixon P.R. and Patel M.V.: Diffusion coefficients of polymer chains in the diffusion layer adjacent to a swollen hydrophilic matrix, J. Pharm. Sci. 1997, 86, 1293-1298.
    • (1997) J. Pharm. Sci. , vol.86 , pp. 1293-1298
    • Ju, R.T.C.1    Nixon, P.R.2    Patel, M.V.3
  • 4
    • 0030829660 scopus 로고    scopus 로고
    • A new ternary polymeric matrix system for controlled drug delivery for highly soluble drugs: 1. Diltiazem hydrochloride
    • Kim H. and Fassihi R.: A new ternary polymeric matrix system for controlled drug delivery for highly soluble drugs: 1. Diltiazem hydrochloride, Pharm. Res. 1997, 14(10), 1415-1421.
    • (1997) Pharm. Res. , vol.14 , Issue.10 , pp. 1415-1421
    • Kim, H.1    Fassihi, R.2
  • 5
    • 0344474555 scopus 로고    scopus 로고
    • Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration
    • DOI 10.1016/S0168-3659(97)00141-7, PII S0168365997001417
    • Nellore R.V., Rekhi G.S., Hussain A.S., Tillman L.G. and Augsburger L.: Development of metoprolol tartrate extended release matrix tablet formulations for regulatory policy consideration, J. Control Rel. 1998, 50, 247-256. (Pubitemid 28044119)
    • (1998) Journal of Controlled Release , vol.50 , Issue.1-3 , pp. 247-256
    • Nellore, R.V.1    Singh, R.G.2    Hussain, A.S.3    Tillman, L.G.4    Augsburger, L.L.5
  • 7
    • 77950050867 scopus 로고    scopus 로고
    • A new reverse phase high performance liquid chromatographic method for analysis of rofecoxib in tablets
    • Nagoji K.E.V., Vijayasrinivas S., Kiran Kumar M., Mathivana N. and Satish Kumar M.: A new reverse phase high performance liquid chromatographic method for analysis of rofecoxib in tablets, Ind. J. Pharm. Sci. 2001, 66(1), 129-130.
    • (2001) Ind. J. Pharm. Sci. , vol.66 , Issue.1 , pp. 129-130
    • Nagoji, K.E.V.1    Vijayasrinivas, S.2    Kiran Kumar, M.3    Mathivana, N.4    Satish Kumar, M.5
  • 8
    • 36048976645 scopus 로고    scopus 로고
    • Formulation and release characteristics of sustained release diltiazem hydrochloride tablet
    • Pandey V.P., Manavalan R. and Ganesh K.S.: Formulation and release characteristics of sustained release diltiazem hydrochloride tablet, Ind. J. Pharm. Sci. 2003, 65(1), 44-47.
    • (2003) Ind. J. Pharm. Sci. , vol.65 , Issue.1 , pp. 44-47
    • Pandey, V.P.1    Manavalan, R.2    Ganesh, K.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.